When Wade D. Miquelon joined Acadia Healthcare’s board in January 2012, he brought 17 years of Procter & Gamble experience providing foundational knowledge for corporate governance in large, complex organizations. His P&G tenure from 1989 to 2006 included progressively responsible positions culminating in senior financial officer roles managing multi-billion dollar operations across multiple continents.

Miquelon spent five years at P&G headquarters in Cincinnati followed by 12 years in international assignments, developing understanding of both centralized corporate functions and decentralized regional operations. This dual perspective applies to Acadia Healthcare’s model combining corporate oversight from Franklin, Tennessee headquarters with operational autonomy at individual facilities adapting to local market conditions and regulatory requirements.

His final P&G role as vice president of finance for Western Europe involved serving as senior financial officer for 17-country operations responsible for 30 percent of total company sales. Managing such significant revenue responsibility required sophisticated financial controls, performance measurement systems, and risk management frameworks. Acadia Healthcare operates with similar complexity across behavioral health, requiring board members who understand multi-unit operations with varying profitability profiles and growth trajectories.

Miquelon also served as director and investment partner of I Ventures, P&G’s venture capital fund, evaluating emerging technologies and business models for potential investment. This experience assessing innovation opportunities within large corporations provides perspective applicable to Acadia Healthcare’s technology investments in electronic health records, patient monitoring systems, and digital health platforms enhancing care delivery.

His work co-founding Emmperative, an enterprise marketing management software joint venture between P&G and other entities, demonstrated entrepreneurial capabilities within corporate structures. He served as CFO and senior vice president of business development and human resources for the venture, combining financial oversight with operational responsibilities—experience relevant to healthcare company board oversight balancing financial performance with quality metrics and workforce management.

P&G’s operational excellence culture emphasizes continuous improvement, process standardization, and data-driven decision making. Miquelon’s immersion in this environment for nearly two decades informs his board contributions at Acadia Healthcare, where quality metrics, performance measurement, and operational efficiency remain critical priorities for facilities serving high-acuity patients requiring intensive clinical interventions alongside achieving financial sustainability.